Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.19%64 EV-to-EBIT is 103.14 as of Sep. 14, 2026, which is 181% above its 10-year median of 36.66. GuruFocus rates TSE:3446 with a GF Score™ of 64/100 and a GF Value™ of 円1,801.44 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 475 Medical Devices & Instruments companies, JTEC ranks worse than 91.79% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, JTEC's Enterprise Value is 円9,394 Mil.
JTEC's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was 円91 Mil. Therefore, JTEC's EV-to-EBIT for today is 103.14.
The historical rank and industry rank for JTEC's EV-to-EBIT or its related term are showing as below:
TSE:3446'
s EV-to-EBIT Range Over the Past 10 Years
Min: -902.95 Med: 36.66 Max: 2866.11
Current: 103.14
During the past 10 years, the highest EV-to-EBIT of JTEC was 2866.11. The lowest was -902.95. And the median was 36.66.
TSE:3446's EV-to-EBIT is ranked worse than 91.79% of 475
companies
in the Medical Devices & Instruments industry
Industry Median: 18.05
vs TSE:3446: 103.14
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
JTEC's Enterprise Value for the quarter that ended in Jun. 2026 was 円10,830 Mil.
JTEC's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC EV-to-EBIT Related Terms
JTEC EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for JTEC's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JTEC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where JTEC's EV-to-EBIT falls into.
JTEC's current Enterprise Value is 円9,394 Mil.
JTEC's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a EV-to-EBIT of 103.14 as of Sep. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JTEC and its competitors. This is 181% above median its historical median of 36.66. According to the industry distribution chart, JTEC ranks #436 out of 475 companies in the Medical Devices & Instruments industry, placing it in the top 91.8%.
Is JTEC's EV-to-EBIT too high?
JTEC's current EV-to-EBIT of 103.14 is 181% above median its 10-year median of 36.66. The Medical Devices & Instruments industry median EV-to-EBIT is 18.05. JTEC's value of 103.14 is 471.4% above this industry median. Based on the distribution chart, JTEC ranks #436 out of 475 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JTEC has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #436 out of 475 companies for EV-to-EBIT. This places JTEC in the lower half of its industry. The industry median EV-to-EBIT is 18.05. JTEC's value of 103.14 is 471.4% above this benchmark. While the company's 10-year median is 36.66 vs. the industry median of 18.05, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.05, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current EV-to-EBIT of 103.14 is 471.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current EV-to-EBIT is 103.14, which is 181% above median its own 10-year median of 36.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,801.44, compared to a current price of 円1,607.00 — trading 10.8% below its estimated fair value. The current EV-to-EBIT is 103.14, which is 181% above median its 10-year median of 36.66 and 471.4% above the Medical Devices & Instruments industry median of 18.05. JTEC's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For JTEC (TSE:3446), the current EV-to-EBIT is 103.14 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,607.00 is trading 10.8% below its estimated GF Value™ of 円1,801.44.
GuruFocus considers JTEC to be Modestly Undervalued.
Key valuation signals for TSE:3446:
EV-to-EBIT: 103.14 (181% above median its 10-year median of 36.66)
GF Value™: 円1,801.44 vs. price of 円1,607.00 (10.8% below fair value)
Industry Position: 471.4% above the Medical Devices & Instruments median (#436 of 475)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
64GF Score
Get the complete analysis for TSE:3446
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
